Company Intelligence
Deepcell
Deepcell provides enterprise-grade artificial intelligence solutions, delivering specialized Deepcell Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Menlo Park, United States
- Website
- www.deepcell.com
- Founded
- 2017
- Status
- Active
- Products
- 2
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Deepcell is a Healthcare AI company based in Menlo Park, United States, founded in 2017.
Menlo Park AI-powered label-free single-cell morphology platform spun out of Stanford for research and regulated environments.
Verified founder profiles on Brel: Maddison Masaeli PhD, Maddison Masaeli.
What it does
Through the deployment of Deepcell Platform, Deepcell provides computational automation and data intelligence for organizations operating in Artificial Intelligence.
What it builds
Deepcell Platform
Why It Matters
Deepcell provides enterprise-grade artificial intelligence solutions, delivering specialized Deepcell Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Axon Data Suite
Explore Axon Data Suite by Deepcell. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence -
REM-I platform and Axon Data Suite
Explore REM-I platform and Axon Data Suite by Deepcell. Verified AI product intelligence covering core capabilities, Healthcare use…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Deepcell
Industry
Industries served
- Biotechnology
Technologies
Capabilities
Deepcell's Human Foundation Model learns morphological representations from imaging data at single-cell resolution, enabling classification and sorting decisions without predefined antibody panels.…
Features
REM-I platform and Axon Data Suite software for AI-powered, label-free single-cell capture, morphological profiling, and sorting using the Human Foundation Model across…
Deployment
- April 21, 2026: Deepcell launched REM-I OnSite — fully on-premises Axon software deployment with air-gapped data on the instrument.
- Deepcell's commercial team configures deployment models per institution compliance needs rather than forcing a single SaaS architecture.
- April 21, 2026: REM-I OnSite launched for fully on-premises, air-gapped Axon software operation on the instrument.
- Why it matters
- Deepcell matters because single-cell research increasingly collides with enterprise data governance — cloud-first SaaS models fail in pharma R&D and certain national jurisdictions even when algorithms perform well.
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
Partnerships
- 2026: REM-I OnSite targets pharma partners and international placements including China with data localization requirements.
Frequently Asked Questions
What does Deepcell do?
Deepcell specializes in artificial intelligence, developing Deepcell Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Deepcell based and when was it founded?
Deepcell is based in United States and was founded in 2017.
What are the main products offered by Deepcell?
The flagship platform from Deepcell is Deepcell Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Deepcell?
Deepcell primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.